EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion

Ruixin Wu, Chunming Sun, Xi Chen, Runyue Yang, Yuxuan Luan, Xiang Zhao, Panpan Yu, Rongkui Luo, Yingyong Hou, Ruotong Tian, Shasha Bian iD, Yuli Li und 13 weitere

Proceedings of the National Academy of Sciences · 02.04.2024 · 121 (14)

DOI: 10.1073/pnas.2321611121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 28.03.2024. Verfasst von Ruixin Wu und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: 5-Methylcytosine, Glioma, DNA-Binding Proteins, Muscle Proteins. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant glioma exhibits immune evasion characterized by highly expressing the immune checkpoint CD47. RNA 5-methylcytosine(m5C) modification plays a pivotal role in tumor pathogenesis. However, the mechanism underlying m5C-modified RNA metabolism remains unclear, as does the contribution of m5C-modified RNA to the glioma immune microenvironment. In this study, we demonstrate that the canonical 28SrRNA methyltransferase NSUN5 down-regulates β-catenin by promoting the degradation of its mRNA, leading to enhanced phagocytosis of tumor-associated macrophages (TAMs). Specifically, the NSUN5-induced suppression of β-catenin relies on its methyltransferase activity mediated by cysteine 359 (C359) and is not influenced by its localization in the nucleolus. Intriguingly, NSUN5 directly interacts with and deposits m5C on CTNNB1 caRNA (chromatin-associated RNA). NSUN5-induced recruitment of TET2 to chromatin is independent of its methyltransferase activity. The m5C modification on caRNA is subsequently oxidized into 5-hydroxymethylcytosine (5hmC) by TET2, which is dependent on its binding affinity for Fe 2+ and α-KG. Furthermore, NSUN5 enhances the chromatin recruitment of RBFOX2 which acts as a 5hmC-specific reader to recognize and facilitate the degradation of 5hmC caRNA. Notably, hmeRIP-seq analysis reveals numerous mRNA substrates of NSUN5 that potentially undergo this mode of metabolism. In addition, NSUN5 is epigenetically suppressed by DNA methylation and is negatively correlated with IDH1-R132H mutation in glioma patients. Importantly, pharmacological blockage of DNA methylation or IDH1-R132H mutant and CD47/SIRPα signaling synergistically enhances TAM-based phagocytosis and glioma elimination in vivo. Our findings unveil a general mechanism by which NSUN5/TET2/RBFOX2 signaling regulates RNA metabolism and highlight NSUN5 targeting as a potential strategy for glioma immune therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5-MethylcytosineGliomaDNA-Binding ProteinsMuscle ProteinsDioxygenasesHumansbeta CateninChromatinCD47 AntigenRNAImmune EvasionRNA, MessengerMethyltransferasesRNA, Small NuclearTumor MicroenvironmentRNA Splicing FactorsRepressor Proteins

Stichwörter der Autor:innen

CTNNB1NSUN5RBFOX2RNA methylationglioma

Substanzen

5-hydroxymethylcytosine5-Methylcytosinebeta CateninChromatinCD47 AntigenRNARNA, MessengerMethyltransferasesRNA, Small NuclearRBFOX2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • Department of Neurology, Huashan hospital, Fudan University, Shanghai 200040, China.
  • Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Microbiology, Key Laboratory of Medical Molecular Virology (Ministry of Education/ National Health Commission/ Chinese Academy of Medical Sciences), Shanghai Frontiers Science Center of Pathogenic Microorg…
  • Department of Pathology, Zhongshan hospital, Fudan University, Shanghai 200032, China.

ORCID-Profile: Shasha Bian, Hanlin Wang, Minfeng Shu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Wu, R., Sun, C., Chen, X., Yang, R., Luan, Y., Zhao, X., Yu, P., Luo, R., Hou, Y., Tian, R., Bian, S., Li, Y., Dong, Y., Liu, Q., Dai, W., Fan, Z., Yan, R., Pan, B., Feng, S., …, & Shu, M. (2024). NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proceedings of the National Academy of Sciences, 121(14). https://doi.org/10.1073/pnas.2321611121

Vancouver

Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, et al. NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proceedings of the National Academy of Sciences. 2024;121(14). doi:10.1073/pnas.2321611121

BibTeX
@article{Wu2024,
  author = {Wu, Ruixin and Sun, Chunming and Chen, Xi and Yang, Runyue and Luan, Yuxuan and Zhao, Xiang and Yu, Panpan and Luo, Rongkui and Hou, Yingyong and Tian, Ruotong and Bian, Shasha and Li, Yuli and Dong, Yinghua and Liu, Qian and Dai, Weiwei and Fan, Zhuoyang and Yan, Rucheng and Pan, Binyang and Feng, Siheng and Wu, Jing and Chen, Fangzhen and Yang, Changle and Wang, Hanlin and Dai, Haochen and Shu, Minfeng},
  title = {NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {14},
  doi = {10.1073/pnas.2321611121}
}
Kostenlos starten →